semaglutide and small bowel obstruction GLP-1 Receptor Agonists in Diabetes Obesity: A Case Report and Review of Risks and Management glp-1 gastric intestinal obstruction lawyer

This is a serious problem for several reasons: Muscle loss slows your resting metabolic rate, making it harder to keep weight off after stopping the medication Reduced muscle mass increases the risk of falls, fractures, and loss of physical function particularly in older adults The skinny fat phenomenon normal BMI but high body fat percentage is a real outcome of poorly managed GLP-1 use The solution is not to avoid GLP-1 medications

Blissenbach is incredibly knowledgeable and made me feel supported even though I never met her face-to-face

He had no systemic symptoms or medical history of any illness

There is no clinical evidence to suggest that injecting tirzepatide twice a week leads to faster or more sustainable weight loss